Miller Steve's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Dec 11, 2024
- Accession no.
- 0001161697-24-000505
- Filed
- Dec 11, 2024
- Trade date
- Dec 9-10, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.10M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Miller SteveCIK 0001402535 | Officer (Chief Op. & Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2024 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +11,872 | –F1 | – | 686,996 | Direct | |
| Dec 10, 2024 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +50,000 | $4.01 | +$200,500 | 736,996 | Direct | |
| Dec 10, 2024 | Common stock, par value $0.001 per share | SSaleDisposed | −50,000 | $21.93F2,F3 | −$1,096,500 | 686,996 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2024 | Common Stock | MOption exerciseDisposed | −11,872 | $0.00 | $0 | 1,837,176 | Direct | |
| Dec 10, 2024 | Common Stock | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 1,787,176 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
Referenced by the price of 1 transaction in Table I.
- F2
Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
Referenced by the price of 1 transaction in Table I.
- F3
Represents a weighted average price for the shares sold. Shares were sold in a range between $21.73 and $22.09 per share.
Referenced by the price of 1 transaction in Table I.